<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38139027</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>24</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Gut Microbiota and Mitochondria: Health and Pathophysiological Aspects of Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">17198</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms242417198</ELocationID><Abstract><AbstractText>The current understanding of long COVID (LC) is still limited. This review highlights key findings regarding the role of gut microbiota, mitochondria, and the main pathophysiological aspects of LC revealed by clinical studies, related to the complex interplay between infection, intestinal dysbiosis, dysfunctional mitochondria, and systemic inflammation generated in a vicious circle, reflecting the molecular and cellular processes from the "leaky gut" to the "leaky electron transport chain (ETC)" into a quantum leap. The heterogeneity of LC has hindered progress in deciphering all the pathophysiological mechanisms, and therefore, the approach must be multidisciplinary, with a special focus not only on symptomatic management but also on addressing the underlying health problems of the patients. It is imperative to further assess and validate the effects of COVID-19 and LC on the gut microbiome and their relationship to infections with other viral agents or pathogens. Further studies are needed to better understand LC and expand the interdisciplinary points of view that are required to accurately diagnose and effectively treat this heterogeneous condition. Given the ability of SARS-CoV-2 to induce autoimmunity in susceptible patients, they should be monitored for symptoms of autoimmune disease after contracting the viral infection. One question remains open, namely, whether the various vaccines developed to end the pandemic will also induce autoimmunity. Recent data highlighted in this review have revealed that the persistence of SARS-CoV-2 and dysfunctional mitochondria in organs such as the heart and, to a lesser extent, the kidneys, liver, and lymph nodes, long after the organism has been able to clear the virus from the lungs, could be an explanation for LC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ailioaie</LastName><ForeName>Laura Marinela</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-8067-5184</Identifier><AffiliationInfo><Affiliation>Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailioaie</LastName><ForeName>Constantin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litscher</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6287-0130</Identifier><AffiliationInfo><Affiliation>President of the International Society for Medical Laser Applications (ISLA Transcontinental), German Vice President of the German-Chinese Research Foundation (DCFG) for TCM, Honorary President of the European Federation of Acupuncture and Moxibustion Societies, Honorary Professor of China Beijing International Acupuncture Training Center, China Academy of Chinese Medical Sciences, Former Head of Two Research Units and the TCM Research Center at the Medical University of Graz, Auenbruggerplatz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dysbiosis</Keyword><Keyword MajorTopicYN="N">dysfunction</Keyword><Keyword MajorTopicYN="N">electron transport chain (ETC)</Keyword><Keyword MajorTopicYN="N">hyperinflammation</Keyword><Keyword MajorTopicYN="N">immunomodulation</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">quantum</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38139027</ArticleId><ArticleId IdType="pmc">PMC10743487</ArticleId><ArticleId IdType="doi">10.3390/ijms242417198</ArticleId><ArticleId IdType="pii">ijms242417198</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E. Time to use the p-word? Coronavirus enters dangerous new phase. Nature. 2020 doi: 10.1038/d41586-020-00551-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-00551-1</ArticleId><ArticleId IdType="pubmed">33623145</ArticleId></ArticleIdList></Reference><Reference><Citation>Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., Blomberg W.R., Meigs D.D., Hasan M., Patel M., et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J. Neuroimmune Pharmacol. 2020;15:359&#x2013;386. doi: 10.1007/s11481-020-09944-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-020-09944-5</ArticleId><ArticleId IdType="pmc">PMC7373339</ArticleId><ArticleId IdType="pubmed">32696264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020;395:514&#x2013;523. doi: 10.1016/S0140-6736(20)30154-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30154-9</ArticleId><ArticleId IdType="pmc">PMC7159286</ArticleId><ArticleId IdType="pubmed">31986261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157&#x2013;160. doi: 10.23750/abm.v91i1.9397.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Director-General&#x2019;s Opening Remarks at the Media Briefing on COVID19-March 2020.  [(accessed on 5 August 2023)].  Available online:  https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 5 August 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Cheng E. China&#x2019;s Population Drops for the First Time in Decades.  [(accessed on 5 August 2023)].  Available online:  https://www.cnbc.com/2023/01/17/chinas-population-drops-for-the-first-time-in-decades.html.</Citation></Reference><Reference><Citation>Population Europe  Demography &amp; COVID-19.  [(accessed on 5 August 2023)].  Available online:  https://population-europe.eu/network/news-network/demography-covid-19.</Citation></Reference><Reference><Citation>Post-COVID Food and Agricultural Situation  Prepared By: Alan Hallman and United States Department of Agriculture, China Staff. Approved By: Robert Hanson.  [(accessed on 5 August 2023)]; Available online:  https://apps.fas.usda.gov/newgainapi/api/Report/DownloadReportByFileName?fileName=Post-COVID%20Food%20and%20Agricultural%20Situation_Beijing_China%20-%20People%27s%20Republic%20of_CH2023-0022.</Citation></Reference><Reference><Citation>Africa Coronavirus Round-Up: Healthcare Systems in Crisis.  [(accessed on 5 August 2023)].  Available online:  https://country.eiu.com/article.aspx?articleid=719548655&amp;Country=Equatorial%2520Guinea&amp;topic=Economy_4.</Citation></Reference><Reference><Citation>Impact of COVID-19 on People&#x2019;s Livelihoods, Their Health and OUR Food Systems.  [(accessed on 5 August 2023)].  Available online:  https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people%27s-livelihoods-their-health-and-our-food-systems.</Citation></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) J. Gen. Intern. Med. 2020;35:1545&#x2013;1549. doi: 10.1007/s11606-020-05762-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05762-w</ArticleId><ArticleId IdType="pmc">PMC7088708</ArticleId><ArticleId IdType="pubmed">32133578</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue H., Bai X., Wang J., Yu Q., Liu W., Pu J., Wang X., Hu J., Xu D., Li X., et al. Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann. Palliat. Med. 2020;9:1404&#x2013;1412. doi: 10.21037/apm-20-887.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-887</ArticleId><ArticleId IdType="pubmed">32692208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E., Callard F., Stras L., Melville-J&#xf3;hannesson B., Pope R., Alwan A.N. Why the Patient-Made Term &#x2018;Long COVID&#x2019; is needed [version 1; peer review: Awaiting peer review] Wellcome Open Res. 2020;5:224. doi: 10.12688/wellcomeopenres.16307.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research&#x2019;s (NIHR)  Living with COVID: NIHR Publishes Dynamic Themed Review into &#x2018;Ongoing COVID&#x2019; 15 October 2020.  [(accessed on 7 August 2023)].  Available online:  https://www.institutemh.org.uk/news/829-living-with-covid-nihr-publishes-dynamic-themed-review-into-ongoing-covid.</Citation></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P.C., Eggert L.E., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front. Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira C.R., Jason L.A., Unutmaz D., Bateman L., Vernon S.D. Improvement of Long COVID symptoms over one year. Front. Med. 2023;9:1065620. doi: 10.3389/fmed.2022.1065620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1065620</ArticleId><ArticleId IdType="pmc">PMC9868805</ArticleId><ArticleId IdType="pubmed">36698810</ArticleId></ArticleIdList></Reference><Reference><Citation>A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 7 August 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Fischer A., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Staub T., Nazarov P.V., Ollert M., Fagherazzi G. Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infect. Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Badier N., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Benoy C., Ollert M., Fagherazzi G. Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. Int. J. Environ. Res. Public Health. 2022;19:16018. doi: 10.3390/ijerph192316018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmig L.M., Rako Z.A., Ziegler S., Richter M.J., GS A.T., Roller F., Grimminger F., Vad&#xe1;sz I., Seeger W., Herold S., et al. Long-term comprehensive cardiopulmonary phenotyping of COVID-19. Respir. Res. 2022;23:263. doi: 10.1186/s12931-022-02173-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02173-9</ArticleId><ArticleId IdType="pmc">PMC9491263</ArticleId><ArticleId IdType="pubmed">36131349</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J.T., Blau H., Casiraghi E., Bergquist T., Loomba J.J., Callahan T.J., Laraway B., Antonescu C., Coleman B., Gargano M., et al. Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Madlock-Brown C., Baratta J.M., Bhatia A., Davis H., Girvin A., Hill E., Kelly E., Kostka K., Loomba J., et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21:58. doi: 10.1186/s12916-023-02737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect. Dis. 2020;7:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H., Scheibenbogen C. Post-COVID syndrome with fatigue and exercise intolerance: Myalgic encephalomyelitis/chronic fatigue syndrome. Inn. Med. (Heidelb. Ger.) 2022;63:830&#x2013;839. doi: 10.1007/s00108-022-01369-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-022-01369-x</ArticleId><ArticleId IdType="pmc">PMC9281337</ArticleId><ArticleId IdType="pubmed">35925074</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen I.H., Magnus P., Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur. J. Epidemiol. 2022;37:539&#x2013;548. doi: 10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S., Tymoszuk P., Ausserhofer D., Rass V., Pizzini A., Nordmeyer G., H&#xfc;fner K., Kurz K., Weber P.M., Sonnweber T., et al. Phenotyping of Acute and Persistent Coronavirus Disease 2019 Features in the Outpatient Setting: Exploratory Analysis of an International Cross-sectional Online Survey. Clin. Infect. Dis. 2022;75:e418&#x2013;e431. doi: 10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor K., Pearson M., Das S., Sardell J., Chocian K., Gardners S. Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis. J. Transl. Med. 2023;21:775. doi: 10.1186/s12967-023-04588-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04588-4</ArticleId><ArticleId IdType="pmc">PMC10621206</ArticleId><ArticleId IdType="pubmed">37915075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M., Summers L.H. The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020;324:1495&#x2013;1496. doi: 10.1001/jama.2020.19759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19759</ArticleId><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung-Chen Y., Blanco-Alonso S., Ant&#xf3;n-Huguet B., Figueras-L&#xf3;pez C., Ugueto-Rodrigo C. Persistent chest pain after resolution of coronavirus 2019 disease (COVID-19) Semergen. 2020;46((Suppl. 1)):88&#x2013;90. doi: 10.1016/j.semerg.2020.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semerg.2020.06.006</ArticleId><ArticleId IdType="pmc">PMC7287471</ArticleId><ArticleId IdType="pubmed">32680679</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Ettorre G., Gentilini Cacciola E., Santinelli L., De Girolamo G., Spagnolello O., Russo A., Tarsitani L., Ciccozzi M., Mastroianni C.M., d&#x2019;Ettorre G., et al. COVID-19 sequelae in working age patients: A systematic review. J. Med. Virol. 2022;94:858&#x2013;868. doi: 10.1002/jmv.27399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27399</ArticleId><ArticleId IdType="pmc">PMC8661973</ArticleId><ArticleId IdType="pubmed">34655247</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic Fatigue and Postexertional Malaise in People Living with Long COVID: An Observational Study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff Sagy Y., Feldhamer I., Brammli-Greenberg S., Lavie G. Estimating the economic burden of long-COVID: The additive cost of healthcare utilisation among COVID-19 recoverees in Israel. BMJ Glob. Health. 2023;8:e012588. doi: 10.1136/bmjgh-2023-012588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012588</ArticleId><ArticleId IdType="pmc">PMC10357303</ArticleId><ArticleId IdType="pubmed">37463787</ArticleId></ArticleIdList></Reference><Reference><Citation>Biga L.M., Bronson S., Dawson S., Harwell A., Hopkins R., Kaufmann J., LeMaster M., Matern P., Morrison-Graham K., Oja K., et al. Anatomy &amp; Physiology. 1st ed. OpenStax/Oregon State University Corvallis; Corvallis, OR, USA: 2019. Chapter 22.7 Embryonic Development of the Respiratory System; pp. 1529&#x2013;1537.</Citation></Reference><Reference><Citation>Barcik W., Boutin R.C.T., Sokolowska M., Finlay B.B. The Role of Lung and Gut Microbiota in the Pathology of Asthma. Immunity. 2020;52:241&#x2013;255. doi: 10.1016/j.immuni.2020.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.01.007</ArticleId><ArticleId IdType="pmc">PMC7128389</ArticleId><ArticleId IdType="pubmed">32075727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Li C., Gao P., Zhang C., Zhang P., Zhang L., Dai C., Zhang K., Shi B., Liu M., et al. Intestinal microbiota links to allograft stability after lung transplantation: A prospective cohort study. Signal Transduct. Target. Ther. 2023;8:326. doi: 10.1038/s41392-023-01515-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01515-3</ArticleId><ArticleId IdType="pmc">PMC10471611</ArticleId><ArticleId IdType="pubmed">37652953</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Cai G., Chen F., Christiani D.C., Zhang Z., Wang M. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19. Gastroenterology. 2020;158:2298&#x2013;2301.e7. doi: 10.1053/j.gastro.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7270476</ArticleId><ArticleId IdType="pubmed">32234303</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L.A., Mayasich S.A., Mu&#xf1;oz A., Soares H., Petrillo M., Albertini M.C., Lanthier N., Grenga L., Amorim M.J. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. J. Clin. Med. 2022;11:5691. doi: 10.3390/jcm11195691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195691</ArticleId><ArticleId IdType="pmc">PMC9573230</ArticleId><ArticleId IdType="pubmed">36233559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., Townsend L., Savinelli S., Mallon P.W.G. Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets. Front. Mol. Biosci. 2023;10:1157651. doi: 10.3389/fmolb.2023.1157651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1157651</ArticleId><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="pubmed">37179568</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhou Y., Ma J., Zhang Q., Shao J., Liang S., Yu Y., Li W., Wang C. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther. 2023;8:416. doi: 10.1038/s41392-023-01640-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01640-z</ArticleId><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M., Mej&#xed;a J.E., Chaumeil J., Gu&#xe9;ry J.C. Female predisposition to TLR7-driven autoimmunity: Gene dosage and the escape from X chromosome inactivation. Semin. Immunopathol. 2019;41:153&#x2013;164. doi: 10.1007/s00281-018-0712-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0712-y</ArticleId><ArticleId IdType="pubmed">30276444</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection. J. Biol. Regul. Homeost. Agents. 2020;34:339&#x2013;343. doi: 10.23812/Editorial-Conti-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/Editorial-Conti-3</ArticleId><ArticleId IdType="pubmed">32253888</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Frydas I., Kritas S.K. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34:327&#x2013;331. doi: 10.23812/CONTI-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/CONTI-E</ArticleId><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.A.J., Williams A.P., Kovats S. Sex chromosome complement and sex steroid signaling underlie sex differences in immunity to respiratory virus infection. Front. Pharmacol. 2023;14:1150282. doi: 10.3389/fphar.2023.1150282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1150282</ArticleId><ArticleId IdType="pmc">PMC10097973</ArticleId><ArticleId IdType="pubmed">37063266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M., et al. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V., Yelin D., Awwad M., Guaraldi G., Mili&#x107; J., Mussini C., Falcone M., Tiseo G., Carrozzi L., Pistelli F., et al. Characteristics of long-COVID among older adults: A cross-sectional study. Int. J. Infect. Dis. 2022;125:287&#x2013;293. doi: 10.1016/j.ijid.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C.A., Pan D., Melbourne C., Teece L., Aujayeb A., Baggaley R.F., Bryant L., Carr S., Gregary B., Gupta A., et al. Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis. PLoS Med. 2022;19:e1004015. doi: 10.1371/journal.pmed.1004015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004015</ArticleId><ArticleId IdType="pmc">PMC9187071</ArticleId><ArticleId IdType="pubmed">35617423</ArticleId></ArticleIdList></Reference><Reference><Citation>Norredam M., Hayward S., Deal A., Agyemang C., Hargreaves S. Understanding and addressing long-COVID among migrants and ethnic minorities in Europe. Lancet Reg. Health. 2022;19:100427. doi: 10.1016/j.lanepe.2022.100427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100427</ArticleId><ArticleId IdType="pmc">PMC9241826</ArticleId><ArticleId IdType="pubmed">35789882</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturrieta-Zuazo I., Rita C.G., Garc&#xed;a-Soid&#xe1;n A., de Malet Pintos-Fonseca A., Alonso-Alarc&#xf3;n N., Pariente-Rodr&#xed;guez R., Tejeda-Velarde A., Serrano-Villar S., Casta&#xf1;er-Alabau J.L., Nieto-Ga&#xf1;&#xe1;n I. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of COVID-19 Spanish patients. Clin. Immunol. 2020;219:108572. doi: 10.1016/j.clim.2020.108572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108572</ArticleId><ArticleId IdType="pmc">PMC7428760</ArticleId><ArticleId IdType="pubmed">32810602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen A., David J.K., Maden S.K., Wood M.A., Weeder B.R., Nellore A., Thompson R.F. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. J. Virol. 2020;94:e00510-20. doi: 10.1128/JVI.00510-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00510-20</ArticleId><ArticleId IdType="pmc">PMC7307149</ArticleId><ArticleId IdType="pubmed">32303592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy A.S., Wagh P., Vishwakarma S., Akolkar K., Tripathy S., Jali P., Kakrani A.L., Barthwal M., Gurav Y., Kadgi N., et al. Association of human leukocyte antigen class I and class II alleles and haplotypes in COVID-19 infection in a western Indian population. Infect. Genet. Evol. 2023;113:105468. doi: 10.1016/j.meegid.2023.105468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2023.105468</ArticleId><ArticleId IdType="pmc">PMC10273771</ArticleId><ArticleId IdType="pubmed">37331496</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong T.T., Ryutov A., Pandey U., Yee R., Goldberg L., Bhojwani D., Aguayo-Hiraldo P., Pinsky B.A., Pekosz A., Shen L., et al. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine. 2021;67:103355. doi: 10.1016/j.ebiom.2021.103355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103355</ArticleId><ArticleId IdType="pmc">PMC8072072</ArticleId><ArticleId IdType="pubmed">33915337</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280. Erratum in Gut 2022, 71, e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated with Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Spikes L., Krishnamachary B., Ram A.K., Kumar A., Chen L., Chalise P., Dhillon N.K. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S., Jagannathan P., Henrich T.J., Sherif Z.A., Bime C., Quinlan E., Portman M.A., Gennaro M., Rehman J. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) eLife. 2023;12:e86014. doi: 10.7554/eLife.86014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86014</ArticleId><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Boppana S., Perez M.D., Sarkar S., Lowman K.E., Qin K., Sterrett S., Carlin E., Bansal A., Sabbaj S., et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J. Clin. Investig. 2021;131:e140491. doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudd P.A., Remy K.E. Prolonged adaptive immune activation in COVID-19: Implications for maintenance of long-term immunity? J. Clin. Investig. 2021;131:e143928. doi: 10.1172/JCI143928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143928</ArticleId><ArticleId IdType="pmc">PMC7773393</ArticleId><ArticleId IdType="pubmed">33104057</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco L.M., Sage P.T., Sharpe A.H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 2010;236:219&#x2013;242. doi: 10.1111/j.1600-065X.2010.00923.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00923.x</ArticleId><ArticleId IdType="pmc">PMC2919275</ArticleId><ArticleId IdType="pubmed">20636820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fife B.T., Pauken K.E. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann. N. Y. Acad. Sci. 2011;1217:45&#x2013;59. doi: 10.1111/j.1749-6632.2010.05919.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2010.05919.x</ArticleId><ArticleId IdType="pubmed">21276005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianchecchi E., Delfino D.V., Fierabracci A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun. Rev. 2013;12:1091&#x2013;1100. doi: 10.1016/j.autrev.2013.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.05.003</ArticleId><ArticleId IdType="pubmed">23792703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Khan F.I. Investigation of Molecular Interactions Mechanism of Pembrolizumab and PD-1. Int. J. Mol. Sci. 2023;24:10684. doi: 10.3390/ijms241310684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310684</ArticleId><ArticleId IdType="pmc">PMC10341962</ArticleId><ArticleId IdType="pubmed">37445859</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Sans H.M., Forman C.A., Nylander A.N., Ho H.E., Lu S., Goldberg S.A., Hoh R., Tai V., Munter S.E., et al. Plasma Markers of Neurologic Injury and Inflammation in People with Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol.-Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Comeau D., Martin M., Robichaud G.A., Chamard-Witkowski L. Neurological manifestations of post-acute sequelae of COVID-19: Which liquid biomarker should we use? Front. Neurol. 2023;14:1233192. doi: 10.3389/fneur.2023.1233192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1233192</ArticleId><ArticleId IdType="pmc">PMC10400889</ArticleId><ArticleId IdType="pubmed">37545721</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R., Shunmugam L., Naidoo K., Abdool Karim S.S., Wilkins D., Garzino-Demo A., Brechot C., Parthasarathy S., Vahlne A., Nikolich J.&#x17d;. Long COVID: A review and proposed visualization of the complexity of long COVID. Front. Immunol. 2023;14:1117464. doi: 10.3389/fimmu.2023.1117464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodr&#xed;guez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.Z., Ram&#xed;rez-Santana C., Anaya J.M. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahabi M., Ghazanfari T., Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-CoV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int. Immunopharmacol. 2022;112:109183. doi: 10.1016/j.intimp.2022.109183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109183</ArticleId><ArticleId IdType="pmc">PMC9393178</ArticleId><ArticleId IdType="pubmed">36182877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolska K., Zar&#x119;bska-Michaluk D., Poniedzia&#x142;ek B., Jaroszewicz J., Flisiak R., Rzymski P. Overview of autoantibodies in COVID-19 convalescents. J. Med. Virol. 2023;95:e28864. doi: 10.1002/jmv.28864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28864</ArticleId><ArticleId IdType="pubmed">37310140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zebardast A., Hasanzadeh A., Ebrahimian Shiadeh S.A., Tourani M., Yahyapour Y. COVID-19: A trigger of autoimmune diseases. Cell Biol. Int. 2023;47:848&#x2013;858. doi: 10.1002/cbin.11997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11997</ArticleId><ArticleId IdType="pubmed">36740221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients with COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi A.F., Marinkovic A., Prakash S., Sanyaolu A., Smith S. COVID-19 and the Human Gut Microbiome: An Under-Recognized Association. Chonnam Med. J. 2022;58:96&#x2013;101. doi: 10.4068/cmj.2022.58.3.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.4068/cmj.2022.58.3.96</ArticleId><ArticleId IdType="pmc">PMC9535107</ArticleId><ArticleId IdType="pubmed">36245770</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarelli A., Giancola M.L., Fontana A., Piselli P., Binda E., Trivieri N., Mencarelli G., Marchioni L., Vulcano A., De Giuli C., et al. Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms. Front. Microbiol. 2022;13:1049215. doi: 10.3389/fmicb.2022.1049215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1049215</ArticleId><ArticleId IdType="pmc">PMC9763305</ArticleId><ArticleId IdType="pubmed">36560946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdel-Sulkowska E.M. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling. BioMed Res. Int. 2021;2021:7880448. doi: 10.1155/2021/7880448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7880448</ArticleId><ArticleId IdType="pmc">PMC8510788</ArticleId><ArticleId IdType="pubmed">34651049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamble S.R., Dandekar M.P. Implication of microbiota gut-brain axis in the manifestation of obsessive-compulsive disorder: Preclinical and clinical evidence. Eur. J. Pharmacol. 2023;957:176014. doi: 10.1016/j.ejphar.2023.176014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2023.176014</ArticleId><ArticleId IdType="pubmed">37619786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Guo R., Ma Q., Li Y., Wang W., Fan Y., Ju Y., Zhao B., Gao Y., Qian L., et al. Stressful events induce long-term gut microbiota dysbiosis and associated post-traumatic stress symptoms in healthcare workers fighting against COVID-19. J. Affect. Disord. 2022;303:187&#x2013;195. doi: 10.1016/j.jad.2022.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.02.024</ArticleId><ArticleId IdType="pmc">PMC8837476</ArticleId><ArticleId IdType="pubmed">35157946</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B., Ueland T., Lerum T.V., Dahl T.B., Holm K., Barratt-Due A., K&#xe5;sine T., Dyrhol-Riise A.M., Stiksrud B., Tonby K., et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J. Intern. Med. 2022;291:801&#x2013;812. doi: 10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Su Q., Zhang F., Tun H.M., Mak J.W.Y., Lui G.C., Ng S.S.S., Ching J.Y.L., Li A., Lu W., et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat. Commun. 2022;13:6806. doi: 10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkacheva O.N., Klimenko N.S., Kashtanova D.A., Tyakht A.V., Maytesyan L.V., Akopyan A.A., Koshechkin S.I., Strazhesko I.D. Gut Microbiome in Post-COVID-19 Patients Is Linked to Immune and Cardiovascular Health Status but Not COVID-19 Severity. Microorganisms. 2023;11:1036. doi: 10.3390/microorganisms11041036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11041036</ArticleId><ArticleId IdType="pmc">PMC10144658</ArticleId><ArticleId IdType="pubmed">37110459</ArticleId></ArticleIdList></Reference><Reference><Citation>Caio R., Cultrera R., Blanco-M&#xed;guez A., Armanini F., Asnicar F., Catozzi C., Nezi L., Lungaro L., Costanzini A., Guarino M., et al. Gut microbiome features in COVID-19: Analysis of a cohort of hospitalized patients. Microbiota Health Dis. 2023;5:e818. doi: 10.26355/mhd_20233_818.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/mhd_20233_818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Zhou Y., Ma Y., Chen P., Tang J., Yang B., Li H., Liang M., Xue Y., Liu Y., et al. Gut Microbiota Dysbiosis Correlates with Long COVID-19 at One-Year After Discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Weng S., Xia C., Ren Y., Liu Z., Xu Y., Yang X., Wu R., Peng L., Sun L., et al. Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites. BMC Med. 2023;21:264. doi: 10.1186/s12916-023-02972-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02972-x</ArticleId><ArticleId IdType="pmc">PMC10355065</ArticleId><ArticleId IdType="pubmed">37468867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti P., Ilamathi H.S., Todkar K., Germain M. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2. Front. Pharmacol. 2020;11:578599. doi: 10.3389/fphar.2020.578599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.578599</ArticleId><ArticleId IdType="pmc">PMC7485471</ArticleId><ArticleId IdType="pubmed">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoraka S., Samarasinghe A.E., Ghaemi A., Mohebbi S.R. Host mitochondria: More than an organelle in SARS-CoV-2 infection. Front. Cell. Infect. Microbiol. 2023;13:1228275. doi: 10.3389/fcimb.2023.1228275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1228275</ArticleId><ArticleId IdType="pmc">PMC10485703</ArticleId><ArticleId IdType="pubmed">37692170</ArticleId></ArticleIdList></Reference><Reference><Citation>San-Mill&#xe1;n I. The Key Role of Mitochondrial Function in Health and Disease. Antioxidants. 2023;12:782. doi: 10.3390/antiox12040782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12040782</ArticleId><ArticleId IdType="pmc">PMC10135185</ArticleId><ArticleId IdType="pubmed">37107158</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2021;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Trihandini I., Muhtar M., Karunia Sakti D.A., Erlianti C.P. The effect of long-haul COVID-19 toward domains of the health-related quality of life among recovered hospitalized patients. Front. Public Health. 2023;11:1068127. doi: 10.3389/fpubh.2023.1068127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1068127</ArticleId><ArticleId IdType="pmc">PMC10434763</ArticleId><ArticleId IdType="pubmed">37601220</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossini E., Concina D., Rinaldi C., Russotto S., Garhwal D., Zeppegno P., Gramaglia C., Kul S., Panella M. Association Between Plasma Redox State/Mitochondria Function and a Flu-Like Syndrome/COVID-19 in the Elderly Admitted to a Long-Term Care Unit. Front. Physiol. 2021;12:707587. doi: 10.3389/fphys.2021.707587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.707587</ArticleId><ArticleId IdType="pmc">PMC8715756</ArticleId><ArticleId IdType="pubmed">34975514</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D., Giannini M., Oulehri W., Riou M., Marcot C., Pizzimenti M., Debrut L., Charloux A., Geny B., Meyer A. Long Term Follow-Up of Sarcopenia and Malnutrition after Hospitalization for COVID-19 in Conventional or Intensive Care Units. Nutrients. 2022;14:912. doi: 10.3390/nu14040912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14040912</ArticleId><ArticleId IdType="pmc">PMC8880495</ArticleId><ArticleId IdType="pubmed">35215562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanem J., Passadori A., Severac F., Dieterlen A., Geny B., Andr&#xe8;s E. Effects of Rehabilitation on Long-COVID-19 Patient&#x2019;s Autonomy, Symptoms and Nutritional Observance. Nutrients. 2022;14:3027. doi: 10.3390/nu14153027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14153027</ArticleId><ArticleId IdType="pmc">PMC9330709</ArticleId><ArticleId IdType="pubmed">35893881</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Mill&#xe1;n I., Petrache I., D&#x2019;Alessandro A. Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz K., Benitez-Trinidad A.B., Covantes-Rosales C.E., Toledo-Ibarra G.A., Ortiz-Lazareno P.C., Gir&#xf3;n-P&#xe9;rez D.A., Bueno-Dur&#xe1;n A.Y., P&#xe9;rez-D&#xed;az D.A., Barcelos-Garc&#xed;a R.G., Gir&#xf3;n-P&#xe9;rez M.I. Loss of mitochondrial membrane potential (&#x394;&#x3a8;m) in leucocytes as post-COVID-19 sequelae. J. Leukoc. Biol. 2022;112:23&#x2013;29. doi: 10.1002/JLB.3MA0322-279RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MA0322-279RRR</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz K.J.G., Covantes-Rosales C.E., Ben&#xed;tez-Trinidad A.B., Navidad-Murrieta M.S., Razura-Carmona F.F., Carrillo-Cruz C.D., Frias-Delgadillo E.J., P&#xe9;rez-D&#xed;az D.A., D&#xed;az-Benavides M.V., Zambrano-Soria M., et al. Effect of Fucoidan on the Mitochondrial Membrane Potential (&#x394;&#x3a8;m) of Leukocytes from Patients with Active COVID-19 and Subjects That Recovered from SARS-CoV-2 Infection. Mar. Drugs. 2022;20:99. doi: 10.3390/md20020099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md20020099</ArticleId><ArticleId IdType="pmc">PMC8878973</ArticleId><ArticleId IdType="pubmed">35200630</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi A. COVID-19 and Mitochondrial Non-Coding RNAs: New Insights from Published Data. Front. Physiol. 2022;12:805005. doi: 10.3389/fphys.2021.805005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.805005</ArticleId><ArticleId IdType="pmc">PMC8856670</ArticleId><ArticleId IdType="pubmed">35185603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage S.L., Amaral E.P., Hilligan K.L., Laidlaw E., Rupert A., Namasivayan S., Rocco J., Galindo F., Kellogg A., Kumar P., et al. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16&#x2212; Monocytes From COVID-19 Patients. Front. Immunol. 2022;12:799558. doi: 10.3389/fimmu.2021.799558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.799558</ArticleId><ArticleId IdType="pmc">PMC8795739</ArticleId><ArticleId IdType="pubmed">35095880</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G., Mustapic M., Kapogiannis D., Henrich T.J., Lu S., Goldberg S.A., Hoh R., Chen J.Y., Martinez E.O., et al. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Yao P.J., Kapogiannis D. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19. Am. J. Med. 2023;136:824&#x2013;829. doi: 10.1016/j.amjmed.2023.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.03.026</ArticleId><ArticleId IdType="pmc">PMC10106499</ArticleId><ArticleId IdType="pubmed">37072092</ArticleId></ArticleIdList></Reference><Reference><Citation>Siekacz K., Kumor-Kisielewska A., Mi&#x142;kowska-Dymanowska J., Pietrusi&#x144;ska M., Bartczak K., Majewski S., Sta&#x144;czyk A., Piotrowski W.J., Bia&#x142;as A.J. Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications. J. Clin. Med. 2023;12:4253. doi: 10.3390/jcm12134253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12134253</ArticleId><ArticleId IdType="pmc">PMC10342941</ArticleId><ArticleId IdType="pubmed">37445288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gvozdj&#xe1;kov&#xe1; A., Sumbalov&#xe1; Z., Kucharsk&#xe1; J., Rausov&#xe1; Z., Koval&#x10d;&#xed;kov&#xe1; E., Tak&#xe1;csov&#xe1; T., Navas P., L&#xf3;pez-Lluch G., Mojto V., Palacka P. Mountain spa rehabilitation improved health of patients with post-COVID-19 syndrome: Pilot study. Environ. Sci. Pollut. Res. 2023;30:14200&#x2013;14211. doi: 10.1007/s11356-022-22949-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-22949-2</ArticleId><ArticleId IdType="pmc">PMC9510276</ArticleId><ArticleId IdType="pubmed">36151435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G. Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children. Int. J. Mol. Sci. 2023;24:10874. doi: 10.3390/ijms241310874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310874</ArticleId><ArticleId IdType="pmc">PMC10342011</ArticleId><ArticleId IdType="pubmed">37446047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G., Chiran D.A. Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic. Int. J. Mol. Sci. 2022;23:7719. doi: 10.3390/ijms23147719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147719</ArticleId><ArticleId IdType="pmc">PMC9322892</ArticleId><ArticleId IdType="pubmed">35887067</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta C.S., Torices S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A.d.R., Caetano B.C., Martins J.S.C.d.C., et al. Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-&#x3ba;B Non-Canonical Pathway and Mitochondrial Remodeling. Viruses. 2023;15:745. doi: 10.3390/v15030745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n Gim&#xe9;nez V.M., Modrego J., G&#xf3;mez-Garre D., Manucha W., de las Heras N. Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. Int. J. Mol. Sci. 2023;24:12249. doi: 10.3390/ijms241512249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241512249</ArticleId><ArticleId IdType="pmc">PMC10419057</ArticleId><ArticleId IdType="pubmed">37569625</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard M., Shirihai O.S. Mitochondrial signal transduction. Cell Metab. 2022;34:1620&#x2013;1653. doi: 10.1016/j.cmet.2022.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.10.008</ArticleId><ArticleId IdType="pmc">PMC9692202</ArticleId><ArticleId IdType="pubmed">36323233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Ahmad S., Ahmad T., Ali S., Syed M.A. Mitochondrial dynamics and mitophagy in lung disorders. Life Sci. 2021;284:119876. doi: 10.1016/j.lfs.2021.119876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119876</ArticleId><ArticleId IdType="pubmed">34389405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G. Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis. Int. J. Mol. Sci. 2022;23:4268. doi: 10.3390/ijms23084268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084268</ArticleId><ArticleId IdType="pmc">PMC9029451</ArticleId><ArticleId IdType="pubmed">35457086</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillie K., Davies H.E., Keat S.B.K., Ladell K., Miners K.L., Jones S.A., Mellou E., Toonen E.J.M., Price D.A., Morgan B.P., et al. Complement dysregulation is a predictive and therapeutically amenable feature of long COVID. medRxiv. 2023 doi: 10.1101/2023.10.26.23297597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.26.23297597</ArticleId><ArticleId IdType="pubmed">38359836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Reyes I., Chandel N.S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 2020;11:102. doi: 10.1038/s41467-019-13668-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13668-3</ArticleId><ArticleId IdType="pmc">PMC6941980</ArticleId><ArticleId IdType="pubmed">31900386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cant&#xf3; C., Menzies K.J., Auwerx J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 2015;22:31&#x2013;53. doi: 10.1016/j.cmet.2015.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.05.023</ArticleId><ArticleId IdType="pmc">PMC4487780</ArticleId><ArticleId IdType="pubmed">26118927</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie N., Zhang L., Gao W., Huang C., Huber P.E., Zhou X., Li C., Shen G., Zou B. NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 2020;5:227. doi: 10.1038/s41392-020-00311-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00311-7</ArticleId><ArticleId IdType="pmc">PMC7539288</ArticleId><ArticleId IdType="pubmed">33028824</ArticleId></ArticleIdList></Reference><Reference><Citation>Block T., Kuo J. Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome. Clin. Pathol. 2022;15:2632010X221106986. doi: 10.1177/2632010X221106986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2632010X221106986</ArticleId><ArticleId IdType="pmc">PMC9234841</ArticleId><ArticleId IdType="pubmed">35769168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Schultz M.B., Sinclair D.A. NAD+ in COVID-19 and viral infections. Trends Immunol. 2022;43:283&#x2013;295. doi: 10.1016/j.it.2022.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.001</ArticleId><ArticleId IdType="pmc">PMC8831132</ArticleId><ArticleId IdType="pubmed">35221228</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens C.D., Bonin Pinto C., Mukli P., Szarvas Z., Peterfi A., Detwiler S., Olay L., Olson A.L., Li G., Galvan V., et al. Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study. PLoS ONE. 2023;18:e0289508. doi: 10.1371/journal.pone.0289508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0289508</ArticleId><ArticleId IdType="pmc">PMC10399897</ArticleId><ArticleId IdType="pubmed">37535668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano H., Kratz A., Nishino T., Imamura H., Yoshida Y., Shimizu N., Kitano H., Yachie A. Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures. Sci. Rep. 2023;13:11765. doi: 10.1038/s41598-023-38762-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38762-x</ArticleId><ArticleId IdType="pmc">PMC10359400</ArticleId><ArticleId IdType="pubmed">37474783</ArticleId></ArticleIdList></Reference><Reference><Citation>Alegre G.F.S., Pastore G.M. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health. Curr. Nutr. Rep. 2023;12:445&#x2013;464. doi: 10.1007/s13668-023-00475-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-023-00475-y</ArticleId><ArticleId IdType="pmc">PMC10240123</ArticleId><ArticleId IdType="pubmed">37273100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Chen W., Hou P., Liu Z., Zuo M., Liu S., Feng C., Han Y., Li P., Shi Y., et al. NAD+ metabolism-based immunoregulation and therapeutic potential. Cell Biosci. 2023;13:81. doi: 10.1186/s13578-023-01031-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-023-01031-5</ArticleId><ArticleId IdType="pmc">PMC10171153</ArticleId><ArticleId IdType="pubmed">37165408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hool L.C. Elucidating the role of the L-type calcium channel in excitability and energetics in the heart: The ISHR 2020 Research Achievement Award Lecture. J. Mol. Cell. Cardiol. 2022;172:100&#x2013;108. doi: 10.1016/j.yjmcc.2022.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2022.08.001</ArticleId><ArticleId IdType="pubmed">36041287</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri J.W., Dybas J.M., Fazelinia H., Kim M.S., Frere J., Zhang Y., Soto Albrecht Y., Murdock D.G., Angelin A., Singh L.N., et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 2023;15:eabq1533. doi: 10.1126/scitranslmed.abq1533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq1533</ArticleId><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>